{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-042592","form_type":"8-K","ticker":"AIM","cik":"0000946644","company_name":"AIM ImmunoTech Inc.","filed_at":"2026-09-14T20:35:23+00:00","discovered_at":"2026-09-14T20:36:10.230735+00:00","generated_at":"2026-09-14T20:37:08.314251+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"AIM ImmunoTech converts $400K debt to 1.75M shares at $0.228 per share","bullets":["Converted $400,000 of Nov 18, 2025 promissory note into 1,749,434 shares at avg $0.228/share via two exchange agreements.","Shares issued to Streeterville Capital under Section 3(a)(9) exemption; no cash consideration; reduces outstanding note balance.","Stockholders approved conversion at July 15, 2026 special meeting per NYSE American Company Guide Sections 713(a)/(b).","Original note principal $3,301,250; remaining balance outstanding after conversion."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-042592","json":"https://secwatch.observer/filing/0001493152-26-042592.json","markdown":"https://secwatch.observer/filing/0001493152-26-042592.md","text":"https://secwatch.observer/filing/0001493152-26-042592.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/946644/000149315226042592/0001493152-26-042592-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/946644/000149315226042592/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-14T20:37:08.314251+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}